I am uploading pptx. And my professor mention concept in short . And i dont understand. Please provide me concept me in easy and understable form from this pptx and surgery standard book

Reading File
Reading File
Running Command

python -m markitdown "/home/daytona/workspace/attachments/727130ff-e772-47c8-8363-11c77f287b87/Blood products and Blood transfusion.pptx"

Finding Sources
Finding Sources
Running Command

cd /home/daytona/workspace && python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/workspace/attachments/727130ff-e772-47c8-8363-11c77f287b87/Blood products and Blood transfusion.pptx') for i, slide in enumerate(prs.slides): print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: if hasattr(shape, 'text') and shape.text.strip(): print(shape.text) print() "

Reading File
Reading File
Running Command

cd /home/daytona/workspace && python3 -c " import zipfile, os pptx_path = '/home/daytona/workspace/attachments/727130ff-e772-47c8-8363-11c77f287b87/Blood products and Blood transfusion.pptx' with zipfile.ZipFile(pptx_path) as z: slides = sorted([f for f in z.namelist() if f.startswith('ppt/slides/slide') and not 'rels' in f]) print('Slides found:', len(slides)) for s in slides[:5]: print(' ', s) "

Reading File
Finding Sources
Running Command

cd /home/daytona/workspace && python3 -c " import zipfile, xml.etree.ElementTree as ET, re pptx_path = '/home/daytona/workspace/attachments/727130ff-e772-47c8-8363-11c77f287b87/Blood products and Blood transfusion.pptx' ns = {'a': 'http://schemas.openxmlformats.org/drawingml/2006/main', 'p': 'http://schemas.openxmlformats.org/presentationml/2006/main'} def get_text_from_xml(xml_content): root = ET.fromstring(xml_content) texts = [] for r in root.iter('{http://schemas.openxmlformats.org/drawingml/2006/main}r'): t = r.find('{http://schemas.openxmlformats.org/drawingml/2006/main}t') if t is not None and t.text: texts.append(t.text) return ' '.join(texts) with zipfile.ZipFile(pptx_path) as z: slides = sorted([f for f in z.namelist() if f.startswith('ppt/slides/slide') and 'rels' not in f]) for i, slide_path in enumerate(slides): with z.open(slide_path) as f: content = f.read() text = get_text_from_xml(content) print(f'=== SLIDE {i+1} ({slide_path}) ===') print(text[:2000]) print() "

Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a complete, easy-to-understand breakdown of every concept from your professor's slides, backed by Bailey & Love's Surgery and Miller's Anesthesia:

🩸 Blood Products & Blood Transfusion - Complete Easy Guide


1. BLOOD PRODUCTS - What Are They?

When you collect blood from a donor, you don't use it "as is" - you spin it down and separate it into individual components. Each component treats a different problem.
Blood ProductWhat It ContainsWhat It Treats
Whole BloodEverything (RBCs + plasma + platelets)Acute massive blood loss
PRBC (Packed Red Blood Cells)Only red blood cellsAnaemia
PlateletsOnly plateletsThrombocytopenia (low platelet count), bleeding
FFP (Fresh Frozen Plasma)All clotting factorsCoagulopathy, warfarin reversal
CryoprecipitateFibrinogen, Factor VIII, Factor XIII, vWFHaemophilia A, Von Willebrand disease, low fibrinogen
Prothrombin Complex Concentrate (PCC)Factors II, VII, IX, XWarfarin reversal (faster and better than FFP)

Simple Memory Aid for Cryoprecipitate contents: "8, 13, F, vW"

  • Factor 8 (VIII)
  • Factor 13 (XIII)
  • Fibrinogen
  • vWF (von Willebrand Factor)

2. BLOOD PRODUCT OF CHOICE - Quick Reference (Exam Favourite!)

Your slide gives a very important table:
Patient ConditionGive This
AnaemiaFresh blood or PRBC
Thrombocytopenia (low platelets)Platelet concentrate
Patient on HeparinFFP
Patient on WarfarinPCC first choice >> FFP
Von Willebrand diseaseFactor VIII > Cryoprecipitate
Haemophilia A (Factor VIII deficiency)Factor VIII concentrate > Cryoprecipitate
Why PCC over FFP for warfarin? PCC is highly purified and concentrated - it reverses warfarin faster and with less volume, reducing the risk of fluid overload.

3. STORAGE OF BLOOD - The CPD/CPDA/SAGM System

This is the chemistry behind WHY blood doesn't clot in the bag and stays usable.

Storage Solutions & Shelf Life

SolutionShelf LifeKey Point
CPD (Citrate-Phosphate-Dextrose)2-3 weeksClassic solution
CPDA (CPD + Adenine)5 weeksAdenine helps RBC make ATP
SAG-M (Saline-Adenine-Glucose-Mannitol)6 weeksCANNOT be used alone - used as an additive alongside CPD/CPDA

Why doesn't blood clot in the bag? (Breaking down the ingredients)

  • Citrate = chelating agent → binds calcium → removes Ca²⁺ → clotting cascade cannot work (calcium is essential for coagulation)
  • Phosphate = buffering agent → prevents pH from falling → also increases 2,3-BPG → decreases Hb's affinity for O₂ (helps O₂ release to tissues)
  • Dextrose (glucose) = energy source for RBCs → makes ATP to keep cells alive
  • Saline + Mannitol = osmotic agents → prevent red cells from swelling and bursting (haemolysis)

4. HALF-LIFE & STORAGE TEMPERATURES

ProductHalf-life / Shelf LifeStorage Temp
Fresh blood24 hours-
Whole Blood / PRBC2-6 weeks2-6°C (fridge)
Platelets5-7 days20-25°C (room temp, with agitation)
FFP, Cryoprecipitate, PCC2 years-40°C (deep freeze)
Why do platelets need room temperature? Platelets become damaged and lose function if refrigerated. They are kept on a special agitator (rocking device) at room temp.

5. WHEN TO TRANSFUSE? (Transfusion Trigger)

This is a very exam-heavy concept. Old practice was to transfuse if Hb < 10 g/dL - this is now proven wrong and harmful.
Clinical SituationTransfuse When Hb is...
No active bleeding, no symptoms, no upcoming major surgery< 6 g/dL
Active bleeding, symptomatic, or about to undergo major surgery< 8 g/dL

Platelet Transfusion Indications

SituationPlatelet Threshold
Surgery planned< 1,00,000 /µL (1 lakh)
Invasive procedure< 50,000 /µL (50K)
Prophylactic (prevent spontaneous bleeding)< 10,000 /µL (10K)

6. MASSIVE BLOOD TRANSFUSION (MBT)

Definition (any ONE of these):

  • Replacement of the entire blood volume within 24 hours
  • > 10 units of PRBC in 24 hours
  • ≥ 3 units of PRBC in 1 hour when ongoing need is expected
Blood volume = 8% of body weight (e.g., 70 kg person = ~5.6 litres)

Important Numbers to Remember:

  • 1 unit PRBC → raises Hb by 1 g/dL and haematocrit by 3%
  • 1 unit Platelets → raises platelet count by 5,000-10,000 /µL

Time Limits for Transfusion:

  • Whole Blood / PRBC: must be completed within 4 hours
  • Platelets / FFP / Cryoprecipitate: within 20 minutes (once thawed/opened)

7. BALANCED TRANSFUSION STRATEGY (1:1:1 Ratio)

During massive transfusion, you give:
RBC : Platelet : FFP = 1 : 1 : 1

Why?

When you give large volumes of packed red cells only, it dilutes the platelets and plasma proteins (clotting factors) - this is called haemodilution. The patient then develops a bleeding tendency (dilutional coagulopathy). The 1:1:1 ratio mimics whole blood and prevents this from happening. - Bailey & Love's Surgery 28th ed.

8. AUTOLOGOUS TRANSFUSION

"Autologous" = you donate blood to yourself before your own surgery.
  • Up to 5 units can be pre-donated
  • First donation: 40 days before surgery
  • Last donation: 3 days before surgery
  • Interval between donations: 3-4 days
Why is this good? Zero risk of immune reactions, no risk of infection from donor.
Also includes cell salvage - during surgery, shed blood is collected, washed, and returned to the patient.

9. DROP FACTOR (Drip Factor)

The drop factor is the number of drops needed to deliver 1 mL of IV fluid through a giving set.
  • Standard IV giving set: 20 drops/mL
  • Blood transfusion set: 15 drops/mL (wider drops because blood is viscous)
  • Paediatric/Burette set: 60 drops/mL
This helps nurses/doctors calculate the correct drip rate.

10. BLOOD TRANSFUSION REACTIONS

A. Immune-Mediated Reactions

ReactionCauseSymptomsTreatment
Acute HaemolyticABO mismatch (wrong blood given)Burning/pain along vein, fever, hypotension, oliguria (most characteristic sign)STOP transfusion immediately, IV fluids, diuretics
Delayed HaemolyticMinor blood group mismatch (Rh etc.)Jaundice, falling Hb days laterUsually self-limiting
Febrile Non-Haemolytic (FNHTR)Recipient's antibodies attack donor white cellsFever, chills, rigor (NO haemolysis)Stop transfusion, antipyretics
Allergic ReactionPlasma proteins in donor bloodUrticaria, rashAntihistamines
AnaphylaxisSevere IgE-mediated reactionHypotension, bronchospasm, collapseAdrenaline 1:1000 IM (preferred) - 1:10,000 IV only in extremis
TRALIDonor antibodies attack recipient's lung neutrophils (immune)Acute lung injury within 6 hrs - bilateral infiltrates, hypoxiaSupportive - O₂, mechanical ventilation. No diuretics

B. Non-Immune Mediated Reactions

ReactionCause
Fluid overload / TACOToo much volume too fast
Iron overloadMultiple transfusions over time (each unit = ~250 mg iron)
InfectionHIV, Hepatitis B/C, Malaria, Syphilis, bacteria
Coagulation failureDilution of clotting factors
HypothermiaCold blood infused rapidly
HypocalcaemiaCitrate in stored blood chelates patient's calcium
HyperkalaemiaRBCs leak K⁺ during storage
Metabolic acidosis/alkalosisCitrate metabolism

11. TACO vs TRALI (High-Yield Comparison!)

Your professor specifically asked about this - it's a very common exam question.
FeatureTACO (Circulatory Overload)TRALI (Lung Injury)
Full formTransfusion-Associated Circulatory OverloadTransfusion-Related Acute Lung Injury
MechanismToo much fluid overwhelms a weak heartImmune reaction - donor antibodies attack recipient's lung
OnsetWithin 2-6 hoursWithin 6 hours
Pulmonary oedema typeHydrostatic (cardiogenic)Permeability (non-cardiogenic, like ARDS)
Blood pressureHypertensiveHypotensive
Risk factorsHeart failure, renal insufficiency, elderlyAny patient (especially from multiparous female donors)
BNP levelElevatedNormal or mildly elevated
CXRCardiomegaly + pulmonary oedema + pleural effusionsBilateral infiltrates, no cardiomegaly
TreatmentDiuretics (furosemide), reduce fluidNO diuretics - supportive O₂/ventilation only

12. KEY EXAM POINTS (From Slide 6 - "MC" Questions)

QuestionAnswer
Most common transfusion reactionFNHTR (Febrile Non-Haemolytic Transfusion Reaction)
Most common symptom in haemolytic reactionBurning sensation and pain along the vein through which transfusion is done
Most common sign in haemolytic reactionOliguria
In anaesthetized patient, how do you know mismatched transfusion occurred?Hypotension + bleeding from wound site (patient can't feel pain or report burning)

13. BLOOD SUBSTITUTES

When real blood is not available or unsafe:
  • Biomimetic - mimic oxygen-carrying function, are haemoglobin-based
  • Abiotic - synthetic oxygen carriers, are perfluorocarbon-based
Still mostly experimental in clinical use.

Quick Summary Cheat Sheet

PRODUCTS:     WB → PRBC → Platelets → FFP → Cryo → PCC
STORAGE:      CPD=2-3wk | CPDA=5wk | SAGM=6wk (additive)
TEMP:         RBC=2-6°C | Platelets=20-25°C | FFP/Cryo=-40°C
TRIGGER:      Stable=<6 | Bleeding/Surgery=<8
MASSIVE TXN:  >10 units PRBC/24h | 1:1:1 ratio (RBC:Plt:FFP)
REACTIONS:    MC=FNHTR | Haemolytic sign=Oliguria | Anaesthesia=Hypotension+bleeding
TACO vs TRALI: TACO=fluid overload(HTN+diuretics) | TRALI=immune(NO diuretics)

Sources: Bailey & Love's Short Practice of Surgery 28th ed., p. 42-44 | Miller's Anesthesia 10th ed. | Barash Clinical Anesthesia 9th ed. | Your professor's lecture slides (Dr. Rahul Jha, MS General Surgery, NAMS/Bir Hospital)

Can you provide me a lit more detail about this topics from standard book in easy language

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Here is a much more detailed, easy-to-understand explanation of every topic, sourced directly from Goldman-Cecil Medicine, Bailey & Love's Surgery, Barash Clinical Anesthesia, Henry's Laboratory Methods, and Scott-Brown's Surgery:

🩸 Blood Products & Blood Transfusion — Detailed Easy Guide (From Standard Textbooks)


PART 1: BLOOD PRODUCTS IN DETAIL

🔴 Whole Blood

Whole blood contains everything - red cells, white cells, platelets, and all plasma proteins including clotting factors. In civilian practice, it is rarely used because it is seen as an "inefficient" use of a limited resource - you are giving a patient things they may not need. However, in military medicine and trauma, whole blood has a big advantage: it is coagulation-factor rich, and if fresh, it is more metabolically active than stored blood. This is why trauma surgeons are now revisiting "walking blood banks" (soldiers donating fresh blood directly on the battlefield).
  • Bailey & Love's Surgery 28th ed.

🔴 Packed Red Blood Cells (PRBC)

When a unit of whole blood is spun in a centrifuge, the heavy red cells fall to the bottom and the plasma floats on top. The plasma is removed, and what remains is a concentrated pack of red cells - this is PRBC.
  • Volume per unit: approximately 330 mL
  • Haematocrit: 50-70% (much thicker/more concentrated than normal blood which is ~45%)
  • Effect: 1 unit raises Hb by 1 g/dL and haematocrit by 3%
  • Stored in SAG-M (as additive) for up to 6 weeks at 2-6°C
PRBC is the go-to for anaemia. You are giving only what the patient needs (red cells for oxygen carrying), without the extra volume load of whole blood.

🟡 Platelets

Platelets are tiny cell fragments that form the first plug when a blood vessel is cut. Without enough platelets, you bleed from wounds and even spontaneously.
  • Supplied as a pooled platelet concentrate (from 4-6 donors pooled together)
  • Contains approximately 250 × 10⁹/litre platelets
  • Stored on a special agitator (rocking machine) at 20-24°C - room temperature!
  • Shelf life: only 5 days (shortest of all blood products)
  • Effect: 1 unit raises platelets by 5,000-10,000 /µL
Why room temperature? If you refrigerate platelets, they get "activated" and clump together prematurely - they stop working. The gentle rocking prevents them from settling and keeps them functioning.
Platelets are given to patients who are thrombocytopenic (low platelet count) or who have platelet dysfunction (e.g., from aspirin/clopidogrel use) who are bleeding or going for surgery. Patients on clopidogrel who are actively bleeding during major surgery may need continuous platelet infusion throughout the operation - that's how severely clopidogrel blocks platelets.
  • Bailey & Love's Surgery 28th ed.

🟢 Fresh Frozen Plasma (FFP)

FFP is the liquid part of blood (plasma) that has been separated from cells and immediately frozen at -40°C to -50°C. "Fresh frozen" means it was frozen quickly so all the clotting factors are preserved.
  • Contains all coagulation factors (I, II, V, VII, VIII, IX, X, XI) and fibrinogen
  • Shelf life: 2 years frozen
  • Must be thawed before use - once thawed must be used within 20 minutes (the clotting factors degrade quickly)
  • Volume: approximately 200-300 mL per unit
When to use FFP:
  • Active haemorrhage with coagulopathy (clotting failure)
  • Warfarin reversal - warfarin blocks factors II, VII, IX, X; FFP replenishes them
  • Massive transfusion (as part of 1:1:1 ratio)
  • Liver disease patients who can't make clotting factors
Important point on Rhesus: Rh-positive FFP CAN technically be given to an Rh-negative woman. But with large volumes, there may be tiny red cell fragments in the FFP, and this can cause Rh sensitisation in the woman - which is dangerous in future pregnancies. So anti-D immunoglobulin should be considered.
  • Bailey & Love's Surgery 28th ed.

🔵 Cryoprecipitate

This is a supernatant precipitate - what remains when FFP is slowly thawed at 4°C and the white precipitate (which forms at the bottom) is collected and re-frozen.
Contents (memory: "8-13-F-vW"):
  • Factor VIII (antihemophilic factor)
  • Factor XIII (stabilises the clot)
  • Fibrinogen (the "glue" that holds the clot together)
  • von Willebrand Factor (vWF) (needed for platelet adhesion)
  • Stored at -30°C with a 2-year shelf life
  • Given in low-fibrinogen states (hypofibrinogenaemia), Factor VIII deficiency, Von Willebrand disease, and Haemophilia A (if concentrate not available)
Why is fibrinogen so important? During massive haemorrhage, fibrinogen is the first clotting factor to become critically low. Without fibrinogen, clots cannot form at all. Cryoprecipitate is given empirically (without waiting for lab tests) when a patient is bleeding massively.
  • Bailey & Love's Surgery 28th ed.

🟣 Prothrombin Complex Concentrate (PCC)

PCC is a highly purified, concentrated extract made from pooled human plasma. It contains the vitamin K-dependent clotting factors.
Contents:
  • Factor II (prothrombin)
  • Factor IX
  • Factor X
  • Factor VII (may or may not be included - "4-factor PCC" includes it)
Main use: Emergency reversal of warfarin (warfarin blocks all 4 of these factors).
Why PCC is better than FFP for warfarin reversal:
  • PCC works in minutes; FFP takes longer
  • PCC needs small volume (e.g., 50 mL); FFP needs large volume (litres) - huge difference in fluid load
  • PCC carries lower infection risk (it's treated/purified)
  • Bailey & Love's Surgery 28th ed.

🔶 Leukoreduction (Leukodepletion)

Your slide mentions this - what does it mean?
Leukoreduction = filtering out white blood cells (WBCs/leukocytes) from blood products before transfusion.
Why remove WBCs?
  1. Prevent febrile non-haemolytic reactions - the most common transfusion reaction is caused by recipient antibodies attacking donor WBCs, releasing fever-causing cytokines
  2. Prevent variant Creutzfeldt-Jakob disease (vCJD) transmission - prion proteins (the cause of "mad cow" disease in humans) may be carried by WBCs
  3. Reduce immunogenicity - donated WBCs can prime the recipient's immune system, creating antibodies that cause problems in future transfusions
In the UK, universal leukodepletion has been standard practice for all blood components since 1999. As a result, the incidence of FNHTR has dropped dramatically - from as high as 30% down to 0.01-1%.
  • Barash Clinical Anesthesia 9th ed. and Goldman-Cecil Medicine

PART 2: BLOOD STORAGE - THE CHEMISTRY IN DETAIL

Why does blood need special storage solutions?

Fresh blood would clot within minutes in a bag - calcium is needed for clotting, and glucose is needed to keep cells alive. Storage solutions solve all these problems.

Breaking Down Each Ingredient

IngredientRoleHow It Helps
CitrateAnticoagulantChelates (binds and removes) calcium ions - without Ca²⁺, the coagulation cascade stops completely. This is why blood does NOT clot in the bag.
PhosphateBufferPrevents the pH from falling (blood gets acidic during storage due to cell metabolism). Also increases 2,3-BPG levels in RBCs, which lowers haemoglobin's affinity for oxygen, so O₂ is released more readily to tissues.
Dextrose (glucose)Energy sourceRed cells have no mitochondria - they make ATP only by glycolysis (using glucose). ATP is needed to run the sodium-potassium pump that keeps red cells the right shape and stops them from bursting.
AdenineATP synthesisHelps the red cell regenerate ATP from AMP. Without adenine, ATP runs out and cells die rapidly. This is why CPDA lasts 5 weeks vs CPD's 2-3 weeks.
SalineDilutes the packReduces viscosity so blood can actually flow through giving sets.
MannitolOsmotic agentPrevents haemolysis (cells bursting). Acts as an osmotic membrane stabiliser.

SAG-M Note

SAG-M cannot be used alone as a blood storage solution because it does not have citrate (the anticoagulant). It is used as an additive solution - added after the plasma has been removed from CPD-anticoagulated blood. The combination gives the best shelf life of 6 weeks.

PART 3: TRANSFUSION TRIGGERS IN DETAIL

Why did the "Hb 10 g/dL" rule get abandoned?

Historically, doctors transfused everyone to get their Hb above 10 g/dL. Large randomised trials (particularly the TRICC trial) showed this was wrong and harmful:
  • More transfusions = more immune reactions, more infections, more organ failure
  • Patients who were transfused "liberally" had higher morbidity and mortality

Current Restrictive Strategy (from Bailey & Love's Surgery)

Patient TypeTransfuse When Hb <
Stable, not bleeding, not going for surgery6 g/dL
Actively bleeding, symptomatic, pre-operative8 g/dL
Cardiac ischaemia patients8-10 g/dL (higher threshold because the heart is very sensitive to low oxygen)
Septic shock7 g/dL (same outcome as 9 g/dL threshold - Goldman-Cecil Medicine)
The rationale: a haemoglobin of 6 g/dL is perfectly acceptable in a resting patient with no active bleeding - the body compensates by increasing cardiac output and extracting more oxygen from what is available.

PART 4: MASSIVE BLOOD TRANSFUSION - IN DETAIL

What is it?

Any ONE of the following (Henry's Laboratory Methods):
  1. Replacement of one entire blood volume within 24 hours (blood volume = ~5L in a 70 kg adult = 8% of body weight)
  2. Transfusion of >10 units PRBC in 24 hours
  3. Transfusion of ≥3 units PRBC in 1 hour when ongoing need is expected
  4. Blood loss of >150 mL/minute (severe ongoing haemorrhage)

Why Does Coagulopathy Develop in Massive Transfusion?

This is the most important complication - you can understand it step by step:
Step 1: Patient is bleeding massively. You transfuse large volumes of PRBC (red cells only) and crystalloid (saline).
Step 2: The PRBC contains NO platelets and NO clotting factors. The crystalloid further dilutes what's there.
Step 3: The patient's own platelets and clotting factors are now so diluted (haemodilution) that they cannot form effective clots.
Step 4: The patient bleeds even more - a vicious cycle. This is called dilutional coagulopathy.
Additionally:
  • Hypothermia (from cold stored blood) makes clotting enzymes work poorly
  • Acidosis (from poor perfusion) further impairs clotting
  • Calcium depletion - remember, stored blood has citrate which binds calcium. When you give large amounts of stored blood, the citrate binds the patient's own calcium - hypocalcaemia develops, worsening coagulopathy
  • DIC (Disseminated Intravascular Coagulation) can develop from the underlying injury
Together these are called the "Lethal Triad" of massive trauma: Hypothermia + Acidosis + Coagulopathy.

The 1:1:1 Balanced Transfusion Strategy

The solution: give all three components together from the start, in equal proportions:
RBC : FFP : Platelets = 1 : 1 : 1
This mimics whole blood. Multiple military and civilian studies show this reduces mortality compared to giving just red cells. - Henry's Laboratory Methods, Goldman-Cecil Medicine

Complications of Massive Transfusion

ComplicationMechanismKey Feature
HypocalcaemiaCitrate in stored blood binds patient's Ca²⁺Tingling, tetany, cardiac arrhythmia → give IV Calcium gluconate
HyperkalaemiaRBCs leak K⁺ into storage solution over time (stored blood is high in K⁺)Risk of cardiac arrhythmia
HypothermiaCold stored blood (2-6°C) enters patient rapidlyWorsens coagulopathy, causes arrhythmia → use blood warmers
CoagulopathyDilution of clotting factors + plateletsBleeding from all sites → 1:1:1 ratio + cryoprecipitate
Metabolic acidosisCitric acid metabolism + poor tissue perfusionInitially acidosis, may convert to metabolic alkalosis once citrate is metabolised
Iron overloadEach PRBC unit contains ~250 mg elemental ironMainly in patients needing repeated transfusions (e.g., thalassaemia)

PART 5: HAEMORRHAGIC SHOCK CLASSIFICATION (Bonus from Goldman-Cecil)

ClassBlood Loss (mL)% VolumePulseBPUrine OutputMental Status
IUp to 750Up to 15%<100Normal>30 mL/hrSlightly anxious
II750-150015-30%>100Normal20-30 mL/hrMildly anxious
III1500-200030-40%>120Decreased5-15 mL/hrAnxious, confused
IV>2000>40%>140DecreasedNegligibleConfused, lethargic
Class I and II: crystalloid. Class III and IV: crystalloid + blood.

PART 6: TRANSFUSION REACTIONS - DETAILED EXPLANATIONS

🔴 Acute Haemolytic Transfusion Reaction (AHTR)

Frequency: ~1 in 110,000 transfusions (rare but deadly)
What happens step by step:
  1. Wrong blood group is given (most commonly ABO mismatch - e.g., group A blood given to a group O patient)
  2. The recipient already has pre-formed antibodies (anti-A or anti-B IgM antibodies - everyone with blood group O has both)
  3. These antibodies immediately attach to the transfused red cells → form antigen-antibody complexes
  4. This activates the complement cascade → complement drills holes in the red cells → intravascular haemolysis (red cells burst inside blood vessels)
  5. Free haemoglobin floods the blood → damages kidneys → oliguria/acute kidney injury
  6. Clotting cascade is activated → DIC (blood clots everywhere and uses up all clotting factors)
  7. Inflammatory mediators cause hypotension → shock → multi-organ failure
Symptoms:
  • Burning pain along the vein (very first symptom - the patient feels something is wrong immediately)
  • Fever, chills
  • Back/flank pain (kidneys)
  • Hypotension
  • Oliguria (most important sign - a sign of kidney damage from haemoglobin)
  • Dark/red urine (haemoglobinuria)
In an anaesthetised patient: They can't tell you about burning pain. The only clues are:
  • Unexplained hypotension
  • Bleeding from the wound site (DIC consuming all clotting factors)
Management:
  1. Stop transfusion immediately
  2. Keep the IV line open with normal saline
  3. Send samples to blood bank to recheck compatibility
  4. IV fluids to maintain urine output
  5. Diuretics (furosemide/mannitol) to force urine flow and flush the kidneys
  6. Treat DIC and hypotension if present
  • Goldman-Cecil Medicine, Barash Anesthesia

🟡 Febrile Non-Haemolytic Transfusion Reaction (FNHTR)

Frequency: ~1 in 1,100 transfusions - the most common reaction
Definition: Temperature rise of ≥1°C (or >38°C) with or without chills, occurring within 4 hours of transfusion, with NO haemolysis.
Mechanism: There are two ways this happens:
  1. Recipient's antibodies (from previous transfusions or pregnancies) attack donor WBCs (HLA antigens)
  2. During platelet storage, donor WBCs break down and release cytokines (inflammatory signals). These pre-formed cytokines trigger fever when transfused
Symptoms: Fever, chills, rigors, nausea, headache - but NO haemolysis, NO hypotension
Important: You must first rule out haemolytic reaction (which also causes fever) before diagnosing FNHTR.
Treatment: Stop transfusion. Give paracetamol/antipyretics. Usually self-limiting.
Prevention: Leukoreduction (removing WBCs). The incidence dropped from 30% to <1% after universal leukodepletion.
  • Goldman-Cecil Medicine, Scott-Brown's Surgery, Barash Clinical Anesthesia

🟠 Allergic Transfusion Reactions

Frequency: ~1 in 1,200 transfusions
Mechanism: The recipient's immune system reacts to plasma proteins in the donor product (not red cells). This is an IgE-mediated or IgE-like immune response.
Range of severity:
  • Mild: Urticaria (hives), itching, flushing - treat with antihistamines, can sometimes continue transfusion at slower rate
  • Moderate: Angioedema, wheezing
  • Severe (Anaphylaxis): Bronchospasm, hypotension, cardiovascular collapse - stop transfusion, give Adrenaline 1:1,000 IM
Special case - IgA deficiency: Some patients lack IgA and have developed anti-IgA antibodies. When they receive blood containing IgA (from donor plasma), they get anaphylaxis. These patients must receive IgA-deficient donor blood or washed blood products.
Premedication: Antihistamines before transfusion are commonly given to patients with a history of allergic reactions, though studies show mixed results.
  • Goldman-Cecil Medicine, Barash Anesthesia

🔵 TRALI (Transfusion-Related Acute Lung Injury)

Frequency: ~1 in 140,000 - rare, but was the leading cause of transfusion-related death before recent prevention measures
Most commonly after: Platelets, FFP (plasma-containing products)
Mechanism - "Two-hit model":
  • Hit 1: Patient has an underlying condition (surgery, trauma, infection) that has already "primed" the lungs - neutrophils are sitting in the pulmonary capillaries, slightly activated
  • Hit 2: Donor blood contains anti-HLA antibodies (antibodies against white blood cells). These are especially common in blood from multiparous women (women who have had multiple pregnancies develop antibodies against their baby's HLA antigens). When transfused, these antibodies attack the primed neutrophils in the patient's lungs → massive inflammation → capillary leak → fluid floods the air spaces (non-cardiogenic pulmonary oedema)
Symptoms (within 6 hours of transfusion):
  • Sudden severe hypoxia (low oxygen saturation)
  • Hypotension (not hypertension like TACO)
  • Bilateral infiltrates on chest X-ray (snow-storm appearance)
  • No evidence of heart failure
Diagnosis: Bilateral infiltrates + hypoxia within 6 hours of transfusion + NO evidence of cardiogenic oedema
Treatment:
  • Stop transfusion immediately
  • Supportive care only - high-flow oxygen, mechanical ventilation if needed
  • NO diuretics (the oedema is from capillary leak, not fluid overload - diuretics won't help and may cause hypotension)
  • Most patients recover within 2-4 days
  • 5-10% mortality rate
Prevention: Blood services now use plasma predominantly from male donors or tested antibody-negative donors, which has dramatically reduced TRALI incidence.
  • Goldman-Cecil Medicine, Scott-Brown's Surgery, Barash Anesthesia

🟢 TACO (Transfusion-Associated Circulatory Overload)

Frequency: ~1 in 9,000 - actually more common than TRALI
Who gets it: Elderly patients, heart failure, renal failure, patients getting large volumes rapidly
Mechanism: Simple fluid overload. The patient's heart and kidneys cannot handle the extra volume being infused → fluid backs up into the lungs → hydrostatic (cardiogenic) pulmonary oedema
Symptoms (within 2-6 hours, sometimes up to 12 hours):
  • Dyspnoea (breathlessness)
  • Hypertension (key distinguishing feature from TRALI)
  • Tachycardia
  • Raised JVP, peripheral oedema, orthopnoea (can't breathe lying flat)
  • Raised BNP/NT-proBNP (heart stress marker - elevated because the heart is struggling)
Treatment:
  • Stop transfusion or slow it down significantly
  • Diuretics (furosemide) - reduces fluid overload
  • Sit patient upright
  • Supplemental oxygen
  • Goldman-Cecil Medicine, Scott-Brown's Surgery, Miller's Anesthesia

PART 7: TACO vs TRALI - The Full Comparison Table

FeatureTACOTRALI
MechanismToo much fluid, weak heart/kidneysImmune - donor antibodies attack patient's lung neutrophils
Oedema typeHydrostatic (cardiogenic - heart failure)Permeability (non-cardiogenic - capillary leak)
Blood pressureHypertensiveHypotensive
Onset2-6 h (up to 12 h)Within 6 h
BNP levelElevated (>1000 pg/mL)Normal or slightly elevated
CXRCardiomegaly + bilateral oedema + pleural effusionsBilateral infiltrates, no cardiomegaly
Risk factorsHeart failure, elderly, renal insufficiencyAny patient; multiparous donor plasma; ICU patients
TreatmentDiuretics + O₂Supportive O₂/ventilation - NO diuretics
PrognosisGood with treatment5-10% mortality
Brain natriuretic peptideHigh - helps differentiateNormal or low
Key memory trick: TACO = Too much fluid = Hypertension = Diuretics fix it. TRALI = Immune attack on lungs = Hypotension = NO diuretics.

PART 8: AUTOLOGOUS TRANSFUSION - IN DETAIL

"Autologous" means you are your own blood donor.

Pre-Donation (Preoperative Autologous Donation - PAD)

  • Patient donates their own blood before elective surgery
  • This blood is stored and re-transfused during the operation
  • Advantages: Zero risk of immune reaction, no infection risk, no alloimmunisation
  • Disadvantages: Expensive, needs planning, patient must be fit enough to donate
Your professor's protocol:
  • Up to 5 units can be pre-donated
  • First donation: 40 days before surgery (to give the body time to recover)
  • Last donation: 3 days before surgery (fresh enough to be useful)
  • Interval between donations: 3-4 days (time to recover each unit donated)

Intraoperative Cell Salvage

During surgery, blood that spills into the operative field is:
  1. Suctioned up
  2. Anticoagulated
  3. Filtered to remove bone fragments, fat, surgical debris
  4. Washed with saline
  5. Centrifuged to concentrate the red cells
  6. Re-infused back into the patient
This is particularly useful in cardiac surgery, orthopaedic surgery, vascular surgery where blood loss can be very large.
Contraindicated when: cancer surgery (risk of spreading cancer cells), infected field, bowel contents are present.
  • Bailey & Love's Surgery 28th ed.

PART 9: CROSS-MATCHING AND BLOOD GROUPS

Why do we cross-match?

The aim is to ensure the patient receives compatible blood - i.e., the donor's red cells won't be attacked by the patient's antibodies.

Step 1 - ABO and Rhesus Typing

Everyone is either A, B, AB, or O, and either Rhesus positive (+) or negative (-).
Blood GroupRed Cell AntigenPlasma Antibodies
AA antigenAnti-B
BB antigenAnti-A
ABA and B antigensNone (universal recipient)
ONoneAnti-A AND Anti-B (universal donor)
Group O negative = universal donor (no antigens to react with anyone's antibodies) Group AB positive = universal recipient (has no antibodies to react against any donor cells)

Step 2 - Full Cross-Match

  • The patient's serum is mixed with the donor's red cells in the lab
  • If agglutination (clumping) occurs → incompatible - don't use
  • Takes up to 45 minutes

Step 3 - In Emergencies

  • Type-specific blood (only ABO/Rhesus matched): Available in 10-15 minutes
  • Group O negative blood (uncrossmatched): Available immediately - for life-threatening emergencies. Give O- to females of child-bearing age (to prevent Rh sensitisation in future pregnancies) and O+ to males.
  • Bailey & Love's Surgery 28th ed.

PART 10: COAGULOPATHY MANAGEMENT IN MASSIVE HAEMORRHAGE

When a patient is bleeding massively:
1. Balanced 1:1:1 Transfusion - as discussed above, given from the very start
2. Tranexamic Acid (TXA)
  • Most bleeding patients have hyperfibrinolysis - their fibrinolysis system (the system that breaks down clots) goes into overdrive, dissolving every clot that tries to form
  • Tranexamic acid is an antifibrinolytic - it blocks plasmin from dissolving clots
  • Should be given as early as possible (within 3 hours of injury - after 3 hours it can paradoxically worsen outcomes)
  • Bailey & Love's Surgery 28th ed.
3. Fibrinogen/Cryoprecipitate
  • Fibrinogen is the first clotting factor to critically fall during haemorrhage
  • Give cryoprecipitate empirically (don't wait for lab results when bleeding is severe)
4. Laboratory Monitoring
  • PT, APTT, fibrinogen levels
  • Thromboelastometry (TEG/ROTEM) - a point-of-care test that gives a real-time picture of the entire clotting process in minutes. Much faster than sending blood to the lab. Guides targeted treatment.
  • Platelet count - give concentrate if <50,000

PART 11: BLOOD SUBSTITUTES - IN DETAIL

Why do we even need substitutes? Because:
  • Real blood is limited in supply
  • Blood carries infection risk
  • Blood has a short shelf life
  • Blood needs complex storage and matching

Biomimetic (Haemoglobin-Based)

These copy what haemoglobin does - carry oxygen.
  • Made from human or bovine (cow) haemoglobin, chemically modified to work outside red cells
  • Problems: free haemoglobin outside red cells is toxic (causes vasoconstriction, kidney damage) - this is why these products have not yet passed large clinical trials

Abiotic (Perfluorocarbon-Based)

These are completely synthetic - not derived from blood at all.
  • Perfluorocarbons are liquids that dissolve huge amounts of oxygen
  • Must be breathed with high-concentration oxygen for them to work
  • Problems: short half-life, need high FiO₂, some cardiovascular side effects
Both types are still largely experimental - not in routine clinical use. But they represent the future of "bloodless" resuscitation.
  • Bailey & Love's Surgery 28th ed.

MASTER SUMMARY TABLE

TopicKey Facts
PRBCHct 50-70%, 330mL, raises Hb 1g/dL, stored 2-6°C, 6wk
Platelets250×10⁹/L, 20-24°C (agitator), 5 days, raises count 5-10k
FFPAll factors, -40°C, 2yr, give within 20min of thawing
CryoFactor VIII+XIII+Fibrinogen+vWF, -30°C, 2yr
PCCFactor II+VII+IX+X, best for warfarin reversal
Transfusion triggerStable: <6 g/dL
Massive transfusion>10 units/24h OR ≥3 units/1h with ongoing need
Balanced strategyRBC:FFP:Platelets = 1:1:1
Lethal triadHypothermia + Acidosis + Coagulopathy
MC reactionFNHTR (1:1,100)
AHTR signOliguria (awake) / Hypotension+bleeding (anaesthetised)
TRALIHypotensive, bilateral infiltrates, NO diuretics, 5-10% death
TACOHypertensive, raised BNP, respond to diuretics
AutologousUp to 5 units; first donation 40 days before, last 3 days before
Tranexamic acidGive early in massive haemorrhage - blocks fibrinolysis

Sources: Goldman-Cecil Medicine 2 Vol Set (p. 2824-2900) | Bailey & Love's Short Practice of Surgery 28th ed. (p. 42-44) | Barash Clinical Anesthesia 9th ed. (p. 1315-1316) | Henry's Clinical Diagnosis & Laboratory Methods | Scott-Brown's Otorhinolaryngology Head & Neck Surgery (p. 293) | Miller's Anesthesia 10th ed.

Create a quick refrence pdf of this in easy language

Reading File
Running Command

ls /home/daytona/workspace/ && python3 -c "from reportlab.lib.pagesizes import A4; print('reportlab ok')"

Running Command

mkdir -p /home/daytona/workspace/blood-transfusion-pdf

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.